Jane Street’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.9M | Sell |
334,050
-250
| -0.1% | -$48.2K | 0.01% | 889 |
|
|
2025
Q4 | $61.5M | Buy |
334,300
+79,850
| +31% | +$14M | 0.01% | 822 |
|
|
2025
Q3 | $39M | Buy |
254,450
+72,650
| +40% | +$11M | 0.01% | 1095 |
|
|
2025
Q2 | $25.4M | Sell |
181,800
-272,150
| -60% | -$38.1M | 0.01% | 1235 |
|
|
2025
Q1 | $66.7M | Buy |
453,950
+440,700
| +3,326% | +$63.8M | 0.02% | 518 |
|
|
2024
Q4 | $1.74M | Sell |
13,250
-157,700
| -92% | -$22.1M | ﹤0.01% | 4370 |
|
|
2024
Q3 | $26.6M | Buy |
170,950
+4,650
| +3% | +$751K | 0.01% | 1046 |
|
|
2024
Q2 | $25.9M | Buy |
166,300
+156,400
| +1,580% | +$23.5M | 0.01% | 1104 |
|
|
2024
Q1 | $1.34M | Sell |
9,900
-154,900
| -94% | -$20.5M | ﹤0.01% | 4856 |
|
|
2023
Q4 | $22.2M | Sell |
164,800
-160,750
| -49% | -$20.9M | 0.01% | 1183 |
|
|
2023
Q3 | $44.1M | Sell |
325,550
-200,500
| -38% | -$27.4M | 0.01% | 612 |
|
|
2023
Q2 | $75.3M | Buy |
526,050
+292,650
| +125% | +$43.1M | 0.03% | 442 |
|
|
2023
Q1 | $32.4M | Buy |
233,400
+126,850
| +119% | +$17.1M | 0.01% | 703 |
|
|
2022
Q4 | $14.4M | Sell |
106,550
-14,050
| -12% | -$1.76M | 0.01% | 1268 |
|
|
2022
Q3 | $13.2M | Sell |
120,600
-94,400
| -44% | -$12M | 0.01% | 1440 |
|
|
2022
Q2 | $28.4M | Sell |
215,000
-84,300
| -28% | -$11.1M | 0.01% | 868 |
|
|
2022
Q1 | $39.7M | Sell |
299,300
-222,836
| -43% | -$26.7M | 0.01% | 798 |
|
|
2021
Q4 | $60.8M | Sell |
522,136
-188,358
| -27% | -$22.2M | 0.02% | 559 |
|
|
2021
Q3 | $85.3M | Buy |
710,494
+432,044
| +155% | +$50.3M | 0.03% | 394 |
|
|
2021
Q2 | $33.4M | Sell |
278,450
-70,800
| -20% | -$7.77M | 0.01% | 753 |
|
|
2021
Q1 | $34.7M | Sell |
349,250
-124,550
| -26% | -$12.5M | 0.02% | 623 |
|
|
2020
Q4 | $47.4M | Buy |
473,800
+24,150
| +5% | +$2.56M | 0.02% | 468 |
|
|
2020
Q3 | $49.3M | Buy |
449,650
+59,600
| +15% | +$6.63M | 0.03% | 390 |
|
|
2020
Q2 | $41.3M | Buy |
390,050
+208,300
| +115% | +$21.5M | 0.03% | 418 |
|
|
2020
Q1 | $16.2M | Buy |
181,750
+117,550
| +183% | +$11.1M | 0.02% | 536 |
|
|
2019
Q4 | $6.4M | Sell |
64,200
-24,800
| -28% | -$2.33M | 0.01% | 898 |
|
|
2019
Q3 | $7.93M | Buy |
89,000
+86,100
| +2,969% | +$7.47M | 0.01% | 711 |
|
|
2019
Q2 | $239K | Sell |
2,900
-200
| -6% | -$15.7K | ﹤0.01% | 4489 |
|
|
2019
Q1 | $251K | Sell |
3,100
-100
| -3% | -$7.88K | ﹤0.01% | 4441 |
|
|
2018
Q4 | $243K | Buy |
+3,200
| New | +$250K | ﹤0.01% | 4292 |
|
|
2018
Q2 | – | Sell |
-10,000
| Closed | -$699K | – | 4956 |
|
|
2018
Q1 | $699K | Buy |
+10,000
| New | +$693K | ﹤0.01% | 3094 |
|
|
2017
Q4 | – | Sell |
-5,550
| Closed | -$376K | – | 4546 |
|
|
2017
Q3 | $376K | Sell |
5,550
-24,200
| -81% | -$1.53M | ﹤0.01% | 3431 |
|
|
2017
Q2 | $2.03M | Buy |
29,750
+24,750
| +495% | +$1.62M | 0.01% | 1485 |
|
|
2017
Q1 | $311K | Buy |
+5,000
| New | +$291K | ﹤0.01% | 3394 |
|
|
2016
Q4 | – | Sell |
-3,500
| Closed | -$230K | – | 4012 |
|
|
2016
Q3 | $230K | Sell |
3,500
-1,750
| -33% | -$114K | ﹤0.01% | 3566 |
|
|
2016
Q2 | $317K | Sell |
5,250
-13,400
| -72% | -$778K | ﹤0.01% | 3254 |
|
|
2016
Q1 | $1.05M | Buy |
+18,650
| New | +$1.12M | 0.01% | 1807 |
|
|
2015
Q4 | – | Sell |
-6,600
| Closed | -$420K | – | 3975 |
|
|
2015
Q3 | $420K | Buy |
+6,600
| New | +$434K | ﹤0.01% | 2476 |
|
|
2014
Q3 | – | Sell |
-7,900
| Closed | -$587K | – | 2529 |
|
|
2014
Q2 | $587K | Buy |
+7,900
| New | +$571K | 0.01% | 1283 |
|
|
2013
Q3 | – | Sell |
-203,500
| Closed | -$9.63M | – | 2699 |
|
|
2013
Q2 | $9.63M | Buy |
+203,500
| New | +$10.4M | 0.17% | 89 |
|
Other funds holding AZN
IA
VCM
VAM
Jane Street's AZN Position: Q1 2026 in Review
Jane Street opened a new position in AstraZeneca (AZN) in Q1 2026: 844,701 shares worth $167M. The stake represents 0.02% of the portfolio and ranks #454 among its holdings. This is a return to the name: Jane Street previously reported a position in AZN as recently as Q3 2025.
Jane Street first reported a position in AZN in Q3 2013 and has held it in 44 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Jane Street held 844,701 shares of AstraZeneca worth $167M as of Q1 2026.
- AstraZeneca was a new Jane Street position in Q1 2026.
- AstraZeneca made up 0.02% of Jane Street's portfolio in Q1 2026, its #454 holding.
- Jane Street first reported a position in AstraZeneca in Q3 2013 and has held it in 44 quarters since.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.